EyePoint, Inc. (EYPT) Current Ratio
- Current ratio · latest quarter: Value 4.50×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.50× | Current assets / current liabilities. $188.82M ÷ $41.94M ≈ 4.50× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 188.82M USD | Assets, Current |
| Current obligations | 41.94M USD | Liabilities, Current |
| Cash and equivalents | 110.46M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 70.01M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | (m) | |
| Inventory | 1.88M USD | Inventory, Net |
| Payables | 17.27M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $188.82M | $41.94M | $110.46M | $70.01M | (m) | $1.88M | $17.27M | (m) | 4.50× |
| 2026-03-31 | $249.50M | $37.46M | $77.71M | $144.83M | (m) | $1.25M | $18.81M | (m) | 6.66× |
| 2025-12-31 | $328.65M | $37.02M | $101.82M | $204.26M | (m) | $1.81M | $10.49M | (m) | 8.88× |
| 2025-09-30 | $216.11M | $30.09M | $74.58M | $129.44M | (m) | $2.11M | $10.08M | (m) | 7.18× |
| 2025-06-30 | $265.25M | $33.17M | $71.14M | $184.59M | (m) | $2.68M | $19.68M | (m) | 8.00× |
| 2025-03-31 | $326.98M | $41.68M | $85.16M | $233.04M | (m) | $2.13M | $16.42M | (m) | 7.85× |
| 2024-12-31 | $383.31M | $49.05M | $99.70M | $271.21M | (m) | $2.31M | $11.72M | (m) | 7.81× |
| 2024-09-30 | $268.55M | $48.79M | $79.83M | $173.96M | (m) | $2.81M | $7.34M | (m) | 5.50× |
| 2024-06-30 | $294.93M | $62.10M | $90.77M | $189.48M | (m) | $3.67M | $14.30M | (m) | 4.75× |
| 2024-03-31 | $317.71M | $62.58M | $271.01M | $28.34M | (m) | $4.26M | $7.08M | (m) | 5.08× |
| 2023-12-31 | $344.80M | $63.26M | $281.26M | $49.79M | (m) | $3.91M | $6.50M | (m) | 5.45× |
| 2023-09-30 | $150.16M | $63.90M | $133.03M | $2.98M | (m) | $4.58M | $9.58M | (m) | 2.35× |
| 2023-06-30 | $167.12M | $68.92M | $139.60M | $2.94M | (m) | $4.26M | $10.72M | (m) | 2.42× |
| 2023-03-31 | $146.06M | $27.24M | $105.77M | $16.72M | (m) | $4.07M | $9.45M | (m) | 5.36× |
| 2022-12-31 | $172.81M | $34.54M | $95.63M | $48.93M | (m) | $2.89M | $5.92M | (m) | 5.00× |
| 2022-09-30 | $192.10M | $34.26M | $75.36M | $81.90M | (m) | $3.53M | $6.11M | (m) | 5.61× |
| 2022-06-30 | $205.87M | $33.39M | $82.13M | $89.03M | (m) | $3.25M | $7.06M | (m) | 6.17× |
| 2022-03-31 | $219.63M | $31.97M | $101.55M | $89.24M | (m) | $3.34M | $7.30M | (m) | 6.87× |
| 2021-12-31 | $237.75M | $23.66M | $178.59M | $32.97M | (m) | $3.62M | $7.38M | (m) | 10.05× |
| 2021-09-30 | $141.78M | $19.93M | $119.71M | (m) | (m) | $4.57M | $6.64M | (m) | 7.11× |
| 2021-06-30 | $151.83M | $16.25M | $127.63M | (m) | (m) | $5.38M | $5.42M | (m) | 9.34× |
| 2021-03-31 | $159.35M | $13.44M | $138.58M | (m) | (m) | $5.59M | $5.86M | (m) | 11.86× |
| 2020-12-31 | $63.12M | $14.89M | $44.91M | $0.00 | (m) | $5.34M | $4.81M | (m) | 4.24× |
| 2020-09-30 | $47.59M | $12.93M | $28.73M | (m) | (m) | $3.64M | $5.18M | (m) | 3.68× |
| 2020-06-30 | $39.83M | $9.59M | $22.81M | (m) | (m) | $3.77M | $3.88M | (m) | 4.16× |
| 2020-03-31 | $49.69M | $10.30M | $26.30M | (m) | (m) | $3.36M | $5.16M | (m) | 4.83× |
| 2019-12-31 | $41.72M | $11.52M | $22.21M | $0.00 | (m) | $2.14M | $4.19M | (m) | 3.62× |
| 2019-09-30 | $47.06M | $10.37M | $31.76M | (m) | (m) | $2.56M | $5.46M | (m) | 4.54× |
| 2019-06-30 | $58.57M | $10.72M | $44.16M | (m) | (m) | $1.67M | $6.07M | (m) | 5.46× |
| 2019-03-31 | $48.37M | $24.66M | $43.38M | (m) | (m) | $886.00K | $6.32M | (m) | 1.96× |
| 2018-12-31 | $47.60M | $21.46M | $45.26M | $0.00 | (m) | $279.00K | $2.64M | (m) | 2.22× |
| 2018-09-30 | $57.64M | $22.42M | $55.76M | (m) | (m) | (m) | $4.08M | (m) | 2.57× |
| 2018-06-30 | $39.91M | $21.66M | $38.78M | (m) | (m) | $0.00 | $2.94M | (m) | 1.84× |
| 2018-03-31 | $17.68M | $21.21M | $16.35M | (m) | (m) | (m) | $2.76M | (m) | 0.83× |
| 2017-12-31 | $13.64M | $4.25M | $12.88M | (m) | (m) | (m) | $1.48M | (m) | 3.21× |
| 2017-09-30 | $12.55M | $4.28M | $11.83M | (m) | (m) | (m) | $1.76M | (m) | 2.93× |
| 2017-06-30 | $17.74M | $5.29M | $16.90M | (m) | (m) | $0.00 | $1.02M | (m) | 3.35× |
| 2017-03-31 | $16.47M | $4.94M | $12.87M | $2.50M | (m) | (m) | $741.00K | (m) | 3.33× |
| 2016-12-31 | $18.54M | $4.93M | $11.69M | $5.85M | (m) | (m) | $1.11M | (m) | 3.76× |
| 2016-09-30 | $23.50M | $4.84M | $14.31M | $8.24M | (m) | (m) | $1.01M | (m) | 4.85× |
| 2016-06-30 | $29.96M | $5.09M | $15.31M | $13.68M | (m) | (m) | $1.36M | (m) | 5.88× |
| 2016-03-31 | $34.28M | $3.97M | $24.87M | $8.41M | (m) | (m) | $571.00K | (m) | 8.64× |
| 2015-12-31 | $21.86M | $3.88M | $11.21M | $9.88M | (m) | (m) | $303.00K | (m) | 5.63× |
| 2015-09-30 | $25.16M | $2.99M | $14.09M | $9.92M | (m) | (m) | $893.00K | (m) | 8.41× |
| 2015-06-30 | $29.84M | $3.35M | $19.12M | $9.41M | (m) | (m) | $744.00K | (m) | 8.91× |
| 2015-03-31 | $33.08M | $2.22M | $23.01M | $8.65M | (m) | (m) | $812.00K | (m) | 14.91× |
| 2014-12-31 | $37.35M | $2.27M | $29.75M | $5.93M | (m) | (m) | $384.00K | (m) | 16.43× |
| 2014-09-30 | $40.69M | $2.31M | $11.38M | $2.92M | (m) | (m) | $1.10M | (m) | 17.60× |
| 2014-06-30 | $19.34M | $2.13M | $15.33M | $2.94M | (m) | (m) | $464.00K | (m) | 9.10× |
| 2014-03-31 | $22.46M | $2.28M | $18.55M | $2.71M | (m) | (m) | $761.00K | (m) | 9.87× |
| 2013-12-31 | $17.23M | $2.15M | $15.22M | $502.00K | (m) | (m) | $176.00K | (m) | 8.01× |
| 2013-09-30 | $19.11M | $2.86M | $14.55M | $1.91M | (m) | (m) | $1.08M | (m) | 6.69× |
| 2013-06-30 | $12.46M | $3.30M | $6.90M | $3.37M | (m) | (m) | $671.00K | (m) | 3.77× |
| 2013-03-31 | $15.21M | $2.69M | $8.00M | $5.70M | (m) | (m) | $355.00K | (m) | 5.66× |
| 2012-12-31 | $16.81M | $2.08M | $9.41M | $6.31M | (m) | (m) | $215.00K | (m) | 8.07× |
| 2012-09-30 | $18.90M | $3.46M | $8.39M | $9.26M | (m) | (m) | $266.00K | (m) | 5.46× |
| 2012-06-30 | $15.96M | $3.18M | $4.63M | $9.95M | (m) | (m) | $394.00K | (m) | 5.02× |
| 2012-03-31 | $17.89M | $2.59M | $6.38M | $10.09M | (m) | (m) | $346.00K | (m) | 6.91× |
| 2011-12-31 | $19.85M | $2.63M | $8.41M | $10.27M | (m) | (m) | $262.00K | (m) | 7.54× |
| 2011-09-30 | $22.28M | $3.99M | $9.81M | $11.46M | (m) | (m) | $511.00K | (m) | 5.58× |
| 2011-06-30 | $25.37M | $5.03M | $12.91M | $11.22M | (m) | (m) | $328.00K | (m) | 5.04× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |